David R Cornblath

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. pmc National Institute of Neurological Disorders and Stroke (NINDS): advances in understanding and treating neuropathy, 24-25 October 2006; Bethesda, Maryland
    Eva L Feldman
    Department of Neurology, University of Michigan, Ann Arbor, MI 48109 2200, USA
    J Peripher Nerv Syst 13:1-6. 2008
  2. ncbi request reprint Recent advances in HIV neuropathy
    David R Cornblath
    School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Curr Opin Neurol 19:446-50. 2006
  3. doi request reprint The safety profile of dalfampridine extended release in multiple sclerosis clinical trials
    David R Cornblath
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Clin Ther 34:1056-69. 2012
  4. ncbi request reprint Surgical decompression for diabetic sensorimotor polyneuropathy
    David R Cornblath
    Department of Neurology, Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Diabetes Care 30:421-2. 2007
  5. doi request reprint An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy
    Vinay Chaudhry
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Peripher Nerv Syst 15:196-201. 2010
  6. ncbi request reprint Worsening of multifocal motor neuropathy during pregnancy
    Vinay Chaudhry
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Neurology 59:139-41. 2002
  7. doi request reprint Peripheral nerve vasculitis presenting as complex regional pain syndrome
    Sindhu Ramchandren
    Department of Neurology, Wayne State University, Detroit Medical Center, University Health Center 8C20, Detroit, MI 48201, USA
    J Clin Neuromuscul Dis 10:61-4. 2008
  8. ncbi request reprint Peripheral neuropathies in human immunodeficiency virus infection
    Ahmet Hoke
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Suppl Clin Neurophysiol 57:195-210. 2004
  9. doi request reprint A framework for diagnosing and classifying intensive care unit-acquired weakness
    Robert D Stevens
    Division of Neurosciences Critical Care, Department of Anesthesiology Critical Care Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Crit Care Med 37:S299-308. 2009
  10. doi request reprint Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice
    Kenneth C Gorson
    Department of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA
    J Peripher Nerv Syst 15:326-33. 2010

Collaborators

Detail Information

Publications15

  1. pmc National Institute of Neurological Disorders and Stroke (NINDS): advances in understanding and treating neuropathy, 24-25 October 2006; Bethesda, Maryland
    Eva L Feldman
    Department of Neurology, University of Michigan, Ann Arbor, MI 48109 2200, USA
    J Peripher Nerv Syst 13:1-6. 2008
    ..Short-term goals of the workshop were to form a working group for neuropathy, the Peripheral Neuropathy Study Group, and to translate new scientific findings into therapies and complete clinical trials...
  2. ncbi request reprint Recent advances in HIV neuropathy
    David R Cornblath
    School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Curr Opin Neurol 19:446-50. 2006
    ..To describe recent advances in HIV neuropathy...
  3. doi request reprint The safety profile of dalfampridine extended release in multiple sclerosis clinical trials
    David R Cornblath
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Clin Ther 34:1056-69. 2012
    ..Dalfampridine extended-release tablets have been approved by the US Food and Drug Administration to improve walking in patients with multiple sclerosis (MS)...
  4. ncbi request reprint Surgical decompression for diabetic sensorimotor polyneuropathy
    David R Cornblath
    Department of Neurology, Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Diabetes Care 30:421-2. 2007
  5. doi request reprint An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy
    Vinay Chaudhry
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Peripher Nerv Syst 15:196-201. 2010
    ..We conclude that rituximab can be safely given to people with MMN but in this pilot study we were unable to reduce the amount of IVIg required, at least in the regimen used...
  6. ncbi request reprint Worsening of multifocal motor neuropathy during pregnancy
    Vinay Chaudhry
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Neurology 59:139-41. 2002
    ..All were treated with IV immunoglobulin during pregnancy and improved in strength. After pregnancy, strength in all patients returned to the prepregnancy state. The authors conclude that pregnancy may worsen MMN...
  7. doi request reprint Peripheral nerve vasculitis presenting as complex regional pain syndrome
    Sindhu Ramchandren
    Department of Neurology, Wayne State University, Detroit Medical Center, University Health Center 8C20, Detroit, MI 48201, USA
    J Clin Neuromuscul Dis 10:61-4. 2008
    ..To report the clinical, electrodiagnostic, and pathologic findings in 3 patients who presented with complex regional pain syndrome as their primary manifestation of peripheral nerve vasculitis...
  8. ncbi request reprint Peripheral neuropathies in human immunodeficiency virus infection
    Ahmet Hoke
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Suppl Clin Neurophysiol 57:195-210. 2004
  9. doi request reprint A framework for diagnosing and classifying intensive care unit-acquired weakness
    Robert D Stevens
    Division of Neurosciences Critical Care, Department of Anesthesiology Critical Care Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Crit Care Med 37:S299-308. 2009
    ..We propose a simple framework for diagnosing and classifying neuromuscular disorders acquired in critical illness...
  10. doi request reprint Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice
    Kenneth C Gorson
    Department of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA
    J Peripher Nerv Syst 15:326-33. 2010
    ..0001). The CDAS is considered a simple and reproducible tool to classify patients with CIDP according to disease activity and treatment status that can be applied easily in practice and potentially to select patients for clinical trials...
  11. doi request reprint Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties
    Kathleen A Griffith
    Department of Organizational Systems and Adult Health, University of Maryland School of Nursing, Baltimore, MD 21201, USA
    J Peripher Nerv Syst 15:314-25. 2010
    ..However, to improve QUADAS scoring, additional research is needed focusing on other psychometric aspects such as responsiveness of CIPN outcome measures...
  12. pmc Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy
    Vinay Chaudhry
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Peripher Nerv Syst 13:275-82. 2008
    ..In a subset, a more severe demyelinating polyneuropathy may develop...
  13. ncbi request reprint Perioperative bilateral median neuropathy
    Giorgia Melli
    Johns Hopkins Hospital, Johns Hopkins School of Medicine, Baltimore, MD 21287 7681, USA
    Anesthesiology 97:1632-4. 2002
  14. ncbi request reprint Clinical and genetic description of a family with Charcot-Marie-Tooth disease type 1B from a transmembrane MPZ mutation
    Scott D Z Eggers
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Muscle Nerve 29:867-9. 2004
    ..This report furthers the understanding of the clinical and electrophysiological manifestations of MPZ mutations...
  15. ncbi request reprint Guillain-Barré syndrome
    Richard A C Hughes
    Department of Clinical Neuroscience, King s College London School of Medicine, Guy s Hospital, UK
    Lancet 366:1653-66. 2005
    ..Further research is needed to discover treatments to prevent 20% of patients from being left with persistent and significant disability...